Concepedia

Kathleen MacCormack

KM

4

Publications

187

Citations

4

H-Index

2004

Active since

Affiliations

AstraZeneca (United States)(Current)

AstraZeneca (United Kingdom)

Kathleen MacCormack is an author at AstraZeneca (United States) specializing in microbiology, drug resistance, and biochemistry.

Top concepts

BiochemistryMicrobiologyDrug ResistanceMedicinePharmacologyDrug DiscoveryNatural SciencesAntimicrobial ResistanceHealthAntibiotics

Publications per year

2004–2015

4

Publications

4

Small-Molecule Inhibitors of Gram-Negative Lipoprotein Trafficking Discovered by Phenotypic Screening

Sarah M. McLeod, Paul Fleming, Kathleen MacCormack et al. · Journal of Bacteriology · 2015 · 82 citations · Full text

Proteinlipid Interaction, Small-molecule Inhibitors, Outer Membrane Lipoprotein +18

Real‐Time Monitoring of New Delhi Metallo‐β‐Lactamase Activity in Living Bacterial Cells by <sup>1</sup> H NMR Spectroscopy

Junhe Ma, Sarah M. McLeod, Kathleen MacCormack et al. · Angewandte Chemie International Edition · 2014 · 73 citations · Full text

Molecular Characterization of Benzimidazole Resistance in <i>Helicobacter pylori</i>

Scott D. Mills, Wei Yang, Kathleen MacCormack · Antimicrobial Agents and Chemotherapy · 2004 · 22 citations · Full text

Bioorganic Chemistry, Molecular Biology, Single Point Mutation +16

Real‐Time Monitoring of New Delhi Metallo‐β‐Lactamase Activity in Living Bacterial Cells by <sup>1</sup>H NMR Spectroscopy

Junhe Ma, Sarah M. McLeod, Kathleen MacCormack et al. · Angewandte Chemie · 2014 · 10 citations

Microbial Physiology, Living Bacterial Cells, Whole Cells +17

Rows per page

1–4 of 4